The 8 analysts offering 12-month price forecasts for Abcellera Biologics Inc have a median target of 32.00, with a high estimate of 43.00 and a low estimate of 14.00. The median estimate represents a +136.34% increase from the last price of 13.54.
The current consensus among 8 polled investment analysts is to Buy stock in Abcellera Biologics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.02
Reporting Date Nov 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.